These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16037975)

  • 21. The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.
    Pennington C; Chohan G; Mackenzie J; Andrews M; Will R; Knight R; Green A
    Neurosci Lett; 2009 May; 455(1):56-9. PubMed ID: 19429106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants.
    Zerr I; Schulz-Schaeffer WJ; Giese A; Bodemer M; Schröter A; Henkel K; Tschampa HJ; Windl O; Pfahlberg A; Steinhoff BJ; Gefeller O; Kretzschmar HA; Poser S
    Ann Neurol; 2000 Sep; 48(3):323-9. PubMed ID: 10976638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classification of sporadic Creutzfeldt-Jakob disease revisited.
    Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
    Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Eleven years of autopsy on account of Creutzfeldt-Jakob disease in the Netherlands].
    Jansen C; Schuur M; Spliet WG; van Gool WA; van Duijn CM; Rozemuller AJ
    Ned Tijdschr Geneeskd; 2009; 153():A172. PubMed ID: 19785859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance for Creutzfeldt-Jakob disease in China from 2006 to 2007.
    Shi Q; Gao C; Zhou W; Zhang BY; Chen JM; Tian C; Jiang HY; Han J; Xiang NJ; Wang XF; Gao YJ; Dong XP
    BMC Public Health; 2008 Oct; 8():360. PubMed ID: 18928564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sporadic Creutzfeldt-Jakob disease: phenotypic variability].
    Moreno MJ; Romero J
    Neurologia; 2002; 17(7):366-77. PubMed ID: 12236956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Creutzfeldt-Jakob disease in Austria].
    Hainfellner JA; Jellinger K; Diringer H; Guentchev M; Kleinert R; Pilz P; Maier H; Budka H
    Wien Klin Wochenschr; 1996 Dec; 108(23):759-63. PubMed ID: 9092208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different prion conformers target the olfactory pathway in sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Ferrari S; Benedetti D; Sbriccoli M; Rizzuto N; Monaco S
    Ann N Y Acad Sci; 2009 Jul; 1170():637-43. PubMed ID: 19686205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance.
    Heinemann U; Krasnianski A; Meissner B; Varges D; Kallenberg K; Schulz-Schaeffer WJ; Steinhoff BJ; Grasbon-Frodl EM; Kretzschmar HA; Zerr I
    Brain; 2007 May; 130(Pt 5):1350-9. PubMed ID: 17472986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterising the uncommon corticobasal syndrome presentation of sporadic Creutzfeldt-Jakob disease.
    Lee W; Simpson M; Ling H; McLean C; Collins S; Williams DR
    Parkinsonism Relat Disord; 2013 Jan; 19(1):81-5. PubMed ID: 22943965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical findings and diagnostic tests in Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease.
    Krasnianski A; Meissner B; Heinemann U; Zerr I
    Folia Neuropathol; 2004; 42 Suppl B():24-38. PubMed ID: 16903140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings.
    Baiardi S; Capellari S; Ladogana A; Strumia S; Santangelo M; Pocchiari M; Parchi P
    J Alzheimers Dis; 2016; 50(2):465-76. PubMed ID: 26682685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B; Boons J; Cras P
    Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol.
    Collie DA; Sellar RJ; Zeidler M; Colchester AC; Knight R; Will RG
    Clin Radiol; 2001 Sep; 56(9):726-39. PubMed ID: 11585394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychiatric symptoms in patients with sporadic Creutzfeldt-Jakob disease in Germany.
    Krasnianski A; Bohling GT; Harden M; Zerr I
    J Clin Psychiatry; 2015 Sep; 76(9):1209-15. PubMed ID: 25938948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced expression of 14-3-3 proteins in reactive astrocytes in Creutzfeldt-Jakob disease brains.
    Kawamoto Y; Akiguchi I; Jarius C; Budka H
    Acta Neuropathol; 2004 Oct; 108(4):302-8. PubMed ID: 15235801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nigrostriatal pathway in Creutzfeldt-Jakob disease.
    Vital A; Fernagut PO; Canron MH; Joux J; Bezard E; Martin-Negrier ML; Vital C; Tison F
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):809-15. PubMed ID: 19535991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Creutzfeldt-Jakob disease in Kenya.
    Adam AM; Akuku O
    Trop Med Int Health; 2005 Jul; 10(7):710-2. PubMed ID: 15960711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-familial Creutzfeldt-Jakob disease: a study of 53 cases].
    Giraud P; Perret-Liaudet A; Biacabe AG; Deslys JP; Laplanche JL; Chazot G; Kop N
    Rev Neurol (Paris); 2000 Jul; 156(6-7):616-21. PubMed ID: 10891795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EEG in Creutzfeldt-Jakob disease.
    Wieser HG; Schindler K; Zumsteg D
    Clin Neurophysiol; 2006 May; 117(5):935-51. PubMed ID: 16442343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.